This study was planned and conducted to investigate effect of adequate calcium intake on Premenstrual Syndrome (PMS) symptoms in women with PMS who have inadequate calcium intake.
Full Title of Study: “Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome”
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Single (Participant)
- Study Primary Completion Date: November 2015
This study was planned and conducted to investigate effect of adequate calcium intake on Premenstrual Syndrome (PMS) symptoms in women with PMS who have inadequate calcium intake. Thirty one women, aged between 20-28 years, diagnosed with PMS and suitable for inclusion criteria, were participated in study. Participants were allocated to intervention (n=16) and control (n=15) groups randomly.
- Other: Sufficient dietary calcium intake in premenstrual syndrome
- Intervention group was ensured to take at least 1000 mg calcium from foods, 700-800 mg of it from dairy and dairy products, according to Recommended Dietary Allowances (RDA), for two months. These foods were; 50 gr kashkaval cheese, 400 ml milk and 150 gr yogurt for each day.
Arms, Groups and Cohorts
- Experimental: Interventional group
- 8-week follow- up with dietary sufficient calcium intake
- No Intervention: Control group
- 8-week follow- up with no specific diet
Clinical Trial Outcome Measures
- Change in Premenstrual Syndrome Scale (PMSS)
- Time Frame: Eight weeks
- Premenstrual Syndrome Scale (PMSS) was used for symptom assessment at initial and after two menstrual cycles.
- Change in Quality of life scale Short Form (SF-36)
- Time Frame: Eight weeks
Participating in This Clinical Trial
- PMS who have inadequate calcium intake – Regular menstrual cycle – Menstrual flow which occurs every 22 to 35 days and last three to eight days Exclusion Criteria:
- Having any of metabolic diseases – Use oral contraceptive pill – user vitamins and minerals supplements – being smoker
Gender Eligibility: Female
Minimum Age: 20 Years
Maximum Age: 28 Years
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Eastern Mediterranean University
- Provider of Information About this Clinical Study
- Principal Investigator: Merve YURT, Senior Instructor – Eastern Mediterranean University
- Overall Official(s)
- Merve Yurt, MS, Principal Investigator, Eastern Mediterranean University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.